Per Richard Torbjörn Hallberg
Direktor/Vorstandsmitglied bei DOVA PHARMACEUTICALS, INC.
Vermögen: 726 768 $ am 30.04.2024
Ursprung des Netzwerks ersten Grades von Per Richard Torbjörn Hallberg
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 44 | |
| Subsidiary | Pharmaceuticals: Major | 18 | |
Takeda Oy
 Takeda Oy Pharmaceuticals: MajorHealth Technology Takeda Oy manufactures pharmaceutical products. The company offers prescription and over-the-counter medicines, as well as hospital products. Its core therapeutical areas are inflammatory bowel, respiratory and cardiovascular diseases, pain management, and cancer. Takeda was founded in 1946 and is headquartered in Helsinki, Finland.
3
| Subsidiary | Pharmaceuticals: Major | 3 |
Swedish Orphan Biovitrum, Inc.
 Swedish Orphan Biovitrum, Inc. Pharmaceuticals: MajorHealth Technology Swedish Orphan Biovitrum, Inc. operates as an international rare disease company providing access to treatments that make a significant difference for people with rare diseases. Its business areas include haemophilia, immunology and specialty care. The company is headquartered in Waltham, MA.
3
| Subsidiary | Pharmaceuticals: Major | 3 |
Nycomed AB
 Nycomed AB Pharmaceuticals: MajorHealth Technology Nycomed AB With a broad portfolio of products and a powerful pipeline, they work in a wide range of therapeutic areas, particularly cardiology, gastroenterology, osteoporosis, respiratory, and pain and tissue management. Nycomed engaged in all aspects of a product's life, from research and development to customer relations. They also work closely with innovative research-based companies, constantly looking for products with real promise for patients. They believe that everything do matters to someone. So they work carefully to make sure they get what they do right. They focus on results and respond quickly to the needs of patients and healthcare providers, giving them the best possible experience from working with clients. By doing this, they can achieve vision of being the preferred pharmaceutical company.
2
| Private Company | Pharmaceuticals: Major | 2 |
Swedish Orphan Biovitrum (Belgium) SARL
 Swedish Orphan Biovitrum (Belgium) SARL BiotechnologyHealth Technology Swedish Orphan Biovitrum (Belgium) SARL develops treatments for diseases. The private company is based in Zaventem, Belgium. The Belgian company was founded in 2013. Bart Fynaerts has been the CEO of the company since 2021.
2
| Private Company | Biotechnology | 2 |
Ferring Pharmaceuticals, Inc.
 Ferring Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ferring Pharmaceuticals, Inc. develops and markets fertility and endocrinology products. Its products include Bravelle, Repronex, Novarel, Acthrel and Desmopressin Acetate. The company's products are used in treatment of osteoarthritis, prostate cancer, and other infertility related diseases. Ferring Pharmaceuticals was founded in 1951 and is headquartered in Parsippany, NJ.
2
| Subsidiary | Pharmaceuticals: Major | 2 |
Advokatfirman Lindahl KB
 Advokatfirman Lindahl KB Miscellaneous Commercial ServicesCommercial Services Advokatfirman Lindahl KB operates a law firm. It specializes in commercial dispute resolution, mergers and acquisitions, intellectual property, and life sciences. The company was founded on January 1, 1990 and is headquartered in Stockholm, Sweden.
1
| Private Company | Miscellaneous Commercial Services | 1 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Per Richard Torbjörn Hallberg
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal Investor Relations Contact | |
| INVESTOR AB | Financial Conglomerates | Director of Finance/CFO Corporate Officer/Principal | |
| UNITED THERAPEUTICS CORPORATION | Pharmaceuticals: Major | Chief Executive Officer Chief Operating Officer | |
| H. LUNDBECK A/S | Pharmaceuticals: Major | Chairman Corporate Officer/Principal | |
| BAXALTA INC | Biotechnology | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Gambro AB
 Gambro AB Medical SpecialtiesHealth Technology Gambro AB engages in the development and manufacturing of dialysis equipment and blood purification products. It provides products and therapies for kidney and liver dialysis, myeloma kidney therapy, and other extracorporeal therapies for chronic and acute patients. The firm offers products for hemodialysis, acute care, myeloma kidney therapy, and vascular access and water systems. The company was founded by Holger Crafoord in 1964 and is headquartered in Lund, Sweden. | Medical Specialties | Director/Board Member Public Communications Contact Chief Executive Officer Director/Board Member | |
| KARO PHARMA AB (PUBL) | Pharmaceuticals: Major | Chairman Director of Finance/CFO | |
| MEDA AB | Pharmaceuticals: Major | Director of Finance/CFO Investor Relations Contact Director/Board Member | |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Corporate Officer/Principal General Counsel Director/Board Member | |
Investor AB (Investment Company)
 Investor AB (Investment Company) Financial ConglomeratesFinance Investor AB (Investment Company) (Investor-IC) is the investment division of Investor AB (STO: INVE-B; LSE: INU), a Swedish public company established in 1916 as the investment vehicle for the Wallenberg family, which still owns a significant part of the firm. Investor AB is an industrial holding company which manages private equity funds listed on the Swedish stock exchange. Headquartered in Stockholm, Investor-IC is a socially responsible investor which supports the OECD Guidelines for Multinational Enterprises, including anti-corruption and human rights. They are committed to the development of society at large and sponsor youth, education and entrepreneurship activities. | Financial Conglomerates | Portfolio Manager-Equities | |
| University of Massachusetts | College/University | Undergraduate Degree Undergraduate Degree | |
| Copenhagen Business School | College/University | Undergraduate Degree Masters Business Admin | |
| Stockholm School of Economics | College/University | Director/Board Member Graduate Degree | |
| University of Uppsala | College/University | Graduate Degree Undergraduate Degree Graduate Degree | |
| CALLIDITAS THERAPEUTICS AB | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
| University of Copenhagen | College/University | Doctorate Degree Doctorate Degree | |
Takeda A/S
 Takeda A/S Financial ConglomeratesFinance Takeda A/S engages in holding or owning of securities in other companies other than banks. The company was founded on January 4, 2005 and is headquartered in Taastrup, Denmark. | Financial Conglomerates | Chief Tech/Sci/R&D Officer Chief Executive Officer Chief Operating Officer Chief Executive Officer Director/Board Member | |
| Ludwig-Maximilians-Universität München | College/University | Doctorate Degree Doctorate Degree | |
| VERONA PHARMA PLC | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member Chief Executive Officer General Counsel | |
PBM Products LLC
 PBM Products LLC Food: Meat/Fish/DairyConsumer Non-Durables PBM Products LLC entered into an exclusive supply arrangement to introduce the first private-label (store-brand) infant formulas in the United States. Today store-brand infant formulas have become increasingly important to retailers, and an affiliate company, PBM Nutritionals LLC manufactures state-of-the-art formulas for PBM Products and its retail partners. Whether a store brand carries its own retail name or is part of a wholesaler's private-label program, store-brand products give retailers a way to make a higher margin, differentiate themselves from the competition, and win the loyalty of customers. It believes their extensive private-label product lines are helping some of the largest retailers in America accomplish their business goals. In turn, their retail partners are helping them to accomplish its mission. PBM partners with leading food and drug retailers to provide high-quality, competitively priced products to customers labeled under the store brands of companies such as Wal-Mart, Target, Kroger, Loblaws, and Walgreens. | Food: Meat/Fish/Dairy | Chief Executive Officer Corporate Officer/Principal | |
| University of Gothenburg | College/University | Doctorate Degree Doctorate Degree | |
Takeda Pharmaceuticals International AG
 Takeda Pharmaceuticals International AG Pharmaceuticals: MajorHealth Technology Takeda Pharmaceuticals International GmbH develops, manufactures, and distributes pharmaceutical products. It offers medicines in therapeutic areas, such as, cardiovascular and metabolic, oncology, central nervous system, respiratory and immunology, general medicine, and vaccines. The firm also provides packaging, development, contract manufacturing and quality control services. Takeda Pharmaceuticals International was founded in 1874 and is headquartered in Zurich, Switzerland. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer President Corporate Officer/Principal | |
| BONESUPPORT HOLDING AB | Medical Specialties | Director/Board Member Chief Tech/Sci/R&D Officer | |
OxThera AB
 OxThera AB Pharmaceuticals: GenericHealth Technology OxThera AB develops pharmaceutical products for treatment of hyperoxaluria. Its intellectual property includes worldwide patents for compositions and treatment of hyperoxaluria with bacteria and enzymes. The firm?s products in pipeline include Oxabact, for the treatment of primary hyperoxaluria and oxazyme for the prevention of oxalate malabsorption and recurring kidney stones in secondary hyperoxaluria. The company was founded in 2005 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Generic | Director of Finance/CFO Director/Board Member | |
SwedenBIO Service AB
 SwedenBIO Service AB Miscellaneous Commercial ServicesCommercial Services SwedenBIO Service AB is a non-profit company that develops biotechnology, diagnostics, pharmaceuticals, and medical technology. It also offers counseling, education, opinion formation, and investigations. The company was founded in 2002 and is headquartered in Stockholm, Sweden. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| SCANDIC HOTELS GROUP AB | Hotels/Resorts/Cruise lines | Human Resources Officer Human Resources Officer | |
Takeda Pharma A/S (DK)
 Takeda Pharma A/S (DK) Drugstore ChainsRetail Trade Takeda Pharma A/S operates as a pharmaceutical company that provides medicines and products for hospitals, specialists, and general practitioners. It supplies prescription and non-prescription medicines for oncology and gastroenterology diseases. The company was founded on January 2, 1984 and is headquartered in Taastrup, Denmark. | Drugstore Chains | Chief Executive Officer Chairman | |
Novo Nordisk Scandinavia AB
 Novo Nordisk Scandinavia AB Pharmaceuticals: MajorHealth Technology Novo Nordisk Scandinavia AB develops, manufactures and markets pharmaceutical products and services. Its products include medicine for diabetes, hemophilia, growth disorders, and hormone therapy. The company is headquartered in Malmö, Sweden. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
PBM Capital Group LLC
 PBM Capital Group LLC Investment ManagersFinance PBM Capital Group LLC (PBM Capital Group) is a private equity and venture capital firm founded in 2010 by Paul B. Manning. The firm is headquartered in Charlottesville, Virginia. | Investment Managers | Chief Executive Officer Chief Executive Officer General Counsel | |
| CANDEL THERAPEUTICS, INC. | Biotechnology | Chairman Director/Board Member | |
PBM Pharmaceuticals, Inc.
 PBM Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology PBM Pharmaceuticals, Inc. manufactures pharmaceutical products. The private company is based in Charlottesville, VA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Tolerion, Inc.
 Tolerion, Inc. Pharmaceuticals: MajorHealth Technology Tolerion, Inc. operates as a clinical-stage biopharmaceutical firm. It develops and commercializes therapeutics. The firm provides TOL-3034 and TOL-3052 to treat myasthenia gravis and neuromyelitis optica. The company was founded by Lawrence J. Steinman and is headquartered in South San Francisco, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| EVOME MEDICAL TECHNOLOGIES INC. | Medical Specialties | Director/Board Member Chief Executive Officer | |
ImStem Biotechnology, Inc.
 ImStem Biotechnology, Inc. Medical SpecialtiesHealth Technology ImStem Biotechnology, Inc. operates as a biotechnology company. It focuses on developing cell therapeutic products. Its cell therapeutic products are derived from human pluripotent stem cells for tissue repair, treatment of neural, heart, vascular, blood system diseases and autoimmune diseases. The company was founded by Xinghua Victor Pan, Ren-He Xu, Michael Men, and Xiaofang Wang in June 2012 and is headquartered in Farmington, CT. | Medical Specialties | Chief Executive Officer | |
Xalud Therapeutics, Inc.
 Xalud Therapeutics, Inc. BiotechnologyHealth Technology Xalud Therapeutics, Inc. develops novel therapies with several promising therapeutic programs for inflammatory. The firm offers XT-101, a single dosage injection that stops disease progression, eliminates neuropathic pain, and reverses paralysis. It also researches on the applicability of XT-101 for multiple sclerosis and amyotrophic lateral sclerosis. The company was founded by John Forsayeth and Linda Watkins and is headquartered in San Francisco, CA. | Biotechnology | Chairman Director/Board Member | |
| VERRICA PHARMACEUTICALS INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| PHARVARIS N.V. | Pharmaceuticals: Major | Founder Director/Board Member | |
| PROVENTION BIO, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
Evecxia, Inc.
 Evecxia, Inc. Miscellaneous Commercial ServicesCommercial Services Evecxia, Inc. is engaged in biotechnology services. The company was founded by Jacob Jacobsen and Marc Caron and is headquartered in Research Triangle Park, NC. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| TAYSHA GENE THERAPIES, INC. | Biotechnology | Director/Board Member Director/Board Member | |
RareGen LLC
 RareGen LLC Miscellaneous Commercial ServicesCommercial Services RareGen LLC provides strategy, investment, and commercialization for rare disease pharmaceutical products. The company is headquartered in Durham, NC. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| LIQUIDIA CORPORATION | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member General Counsel |
Statistik
International
| Vereinigte Staaten | 20 |
| Schweden | 20 |
| Dänemark | 6 |
| Vereinigtes Königreich | 4 |
| Niederlande | 3 |
Sektoral
| Health Technology | 30 |
| Consumer Services | 9 |
| Finance | 6 |
| Commercial Services | 6 |
| Consumer Non-Durables | 2 |
Operativ
| Director/Board Member | 265 |
| Corporate Officer/Principal | 114 |
| Independent Dir/Board Member | 85 |
| Chairman | 66 |
| Chief Executive Officer | 44 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Sven Håkan Björklund | 46 |
| Åke Mikael Smedeby | 34 |
| Bo Jesper Hansen | 34 |
| Sean Stalfort | 28 |
| Paul Manning | 26 |
| Johannes G. C. P. Schikan | 22 |
| Nancy Wysenski | 20 |
| Alfred Novak | 19 |
| Sven Anders Ullman | 19 |
| Guido Oelkers | 19 |
| Roger Jeffs | 18 |
| Henrik Stenqvist | 16 |
| Lena Elisabeth Svanberg | 16 |
| Staffan Schüberg | 15 |
| Matthew David Tooth | 14 |
- Börse
- Insiders
- Per Richard Torbjörn Hallberg
- Unternehmensverbindungen
